Why Canopy Growth’s (TSX:WEED) Stock Price Has Fallen 57% in 6 Months

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock is down 57% over six months.

Canopy Growth (TSX: WEED)(NYSE:CGC) stock has been tanking over the past six months. Since March 13, it has fallen a whopping 57%. Despite a massive earnings beat in its most recent quarter, WEED just keeps tumbling into the abyss. In this article, I will outline a few main reasons why that is the case.

Rising losses

One big reason why Canopy Growth keeps falling is because it keeps losing money quarter after quarter. At the start of this article, I did mention an earnings beat in the most recent quarter, but I’ll address that shortly. It wasn’t really quite the beat that it appeared to be at first glance.

Apart from that one quarter, Canopy just keeps losing money year after year:

  • In fiscal 2021, it lost $1.6 billion.
  • In 2020, it lost $1.3 billion.
  • Both of these fiscal years also saw operating losses in excess of a billion dollars.

Put simply, the company is just bleeding cash — so much so that it is beginning to dry up the $5 billion in cash it got from Constellation Brands. In 2018, Canopy got a massive infusion of cash from Constellation, which was supposed to be used to grow the business. It was a huge deal at the time. But after $2.9 billion in quarterly losses, the $5 billion is close to being totally used up, and Canopy has very little to show for it.

A deceptive “earnings beat”

Related to Canopy’s long-term earnings trend is its most recent quarter. Technically, earnings were positive to the tune of $389 million. However, this wasn’t really such an impressive feat as it appeared to be. While Canopy did earn $389 million in GAAP terms, it also

  • Lost $187 million from operations; and
  • Had a $165 million net cash outflow from operations.

Put simply, the $389 million in GAAP net income was not supported by operating results or cash flows. It was most likely due to the $685 million in fair-value adjustments Canopy recorded in the quarter, which don’t affect cash profits.

U.S. legalization taking a long time

A final factor contributing to Canopy Growth’s slide is the fact that U.S. legalization is taking an awfully long time. Canadian cannabis legalization is almost three years in the past at this point. The revenue boost that came from that has already occurred, and now deceleration is underway. In order for cannabis companies to continue growing (pardon the pun), they’re going to need to break into new markets. The U.S. is the obvious place to look.

Unfortunately, U.S. legalization is taking much longer than many had hoped. While several U.S. states have legalized cannabis, federal legalization doesn’t look to be happening any time soon. Many progressives hoped that Joe Biden would legalize cannabis, but he isn’t doing so. So, investors are going to have to wait until a new multi-billion-dollar legal market opens for Canada’s biggest cannabis companies. It seems many of them are choosing not to wait, opting to sell their shares instead.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Cannara, Source Energy and CareRx just updated investors. See what $1,000 can buy in these Canadian stocks, plus the risks…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful

Tilray's record revenue came with declining cannabis sales and negative free cash flow, making the investment much more speculative than…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Read more »

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »